Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Don Miller who wrote (4257)	3/8/2000 12:13:00 PM
From: billy d	Respond to of 10280

Does anyone think that MRK's pediatric dosage approval of Sigular have anything to do with the retreat? How about Genentechs's Phase III asthma treatment showing promise. Not that I feel it means all that much but may be good excuses for profit taking after such a strong run. As for today,as I type, SEPR is up 8 on very strong volume.

To: Don Miller who wrote (4257)	3/8/2000 10:17:00 PM
From: Ed Ajootian	Read Replies (2) \| Respond to of 10280

Don, Thanks for the update. So now let me see if I got this straight. SEPR is going for a convertible note financing and has all this great developments and clinical advancements that it has done, but it does not issue any press releases on same. It does the convertible note financing without such news getting in the public domain. It goes to a major medical conference and presents the findings, which are overall pretty positive. It still doesn't put out a press release several days after the end of the conference, recapping what it presented at the conference. What am I missing here folks? What happened, did Timmy B. just take the $10 M from his stock sales and go on a 6 month vacation or something? <g>